BREAKING NEWS

First magic mushroom depression trial hits stumbling block

By REUTERS

APRIL 7, 2013 02:02

LONDON- The world's first clinical trial designed to explore using a hallucinogen from magic mushrooms to treat people with depression has stalled because of British and European rules on the use of illegal drugs in research.

David Nutt, president of the British Neuroscience Association and professor of neuropsychopharmacology at Imperial College London, said he had been granted an ethical green light and funding for the trial, but regulations were blocking it.

"We live in a world of insanity in terms of regulating drugs," he told a neuroscience conference in London on Sunday.

He has previously conducted small experiments on healthy volunteers and found that psilocybin, the psychedelic ingredient in magic mushrooms, has the potential to alleviate severe forms of depression in people who don't respond to other treatments.

China must stop aiding Russia if seeks good relations with West - NATO

By REUTERS

04/25/2024 09:39 PM

Israel willing to consider accepting 20 hostages as part of deal

By JERUSALEM POST STAFF

04/25/2024 09:08 PM

WH: Up to governors, not Biden to call National Guard on campuses

By HANNAH SARISOHN

04/25/2024 08:40 PM

White House: There's not going to be a two-state solution with Hamas

By HANNAH SARISOHN

04/25/2024 08:28 PM